Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Two Sigma Ventures, LP (CIK 1878979) reported $9.6M across 1 reported positions in its SEC 13F filing for 2022-09-30. Largest positions: RXRX ($9.6M, 100.00%), ZY ($0, 0.00%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | RXRX | RECURSION PHARMACEUTICALS IN | $9.6M | 100.00% | 903,400 | Trimmed |
| 2 | ZY | ZYMERGEN INC | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2022-09-30